Beric Berlioz, MD
Interventional Pain Medicine · Jacksonville, FLNPI 1093240061
Payments from drug & device makers
Across 225 payments — averaging $73.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$11K
- Boston Scientific$2K
- Collegium Pharmaceutical, Inc.$660
- Nevro Corp.$431
- Painteq LLC$415
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$368
- plus $2K from 29 others
What the payments were for
- Grants$10,00061%
- Travel & lodging$7475%
- Food & beverage$5,52834%
- Education$2261%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 10 | $10,838 |
| Boston Scientific | 37 | $1,545 |
| Collegium Pharmaceutical, Inc. | 47 | $660 |
| Nevro Corp. | 7 | $431 |
| Painteq LLC | 8 | $415 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 29 | $368 |
| Stryker | 4 | $308 |
| AbbVie | 13 | $303 |
| Abbott | 8 | $248 |
| Tersera Therapeutics LLC | 9 | $208 |
| MML US, Inc. | 1 | $122 |
| Saluda Medical Americas, Inc. | 5 | $118 |
| IBSA Pharma Inc. | 7 | $110 |
| Pfizer | 4 | $80 |
| Almatica Pharma LLC | 4 | $80 |
| Orexo US, Inc. | 3 | $76 |
| Alnylam Pharmaceuticals Inc. | 2 | $54 |
| Valinor Pharma, LLC | 3 | $52 |
| Nalu Medical, Inc. | 2 | $51 |
| Forte Bio-pharma LLC | 3 | $51 |
| Idorsia Pharmaceuticals US Inc | 3 | $50 |
| Vertos Medical, Inc. | 2 | $47 |
| Avanos Medical | 1 | $35 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $35 |
| Lilly USA, LLC | 1 | $26 |
| Lundbeck LLC | 1 | $25 |
| Alevio, LLC | 1 | $22 |
| Tonix Medicines, Inc. | 1 | $22 |
| Globus Medical | 1 | $21 |
| Johnson & Johnson | 1 | $19 |
| Amneal Pharmaceuticals LLC | 1 | $18 |
| Si-bone, Inc. | 1 | $18 |
| Scilex Pharmaceuticals Inc. | 1 | $17 |
| Trevena, Inc. | 1 | $16 |
| Indivior Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SYNCHROMED$10,000
- INTELLIS ADAPTIVESTIM$634
- WaveWriter Alpha Prime 16$283
- Omnia$267
- mild Device Kit$195
- PAINTEQ$186
- WAVEWRITER ALPHA$134
- ReActiv8$122
How this compares
$16,501 in reported general payments places this provider in the 75th percentile of 278 interventional pain medicine providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Xtampza ErOxycodone Myristate | 355 | $165,442 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 1,900 | $80,791 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 2,120 | $69,859 |
| OxycontinOxycodone Hcl | 111 | $69,699 |
| BelbucaBuprenorphine Hcl | 46 | $30,834 |
| Oxycodone Hcl | 1,628 | $30,204 |
| NucyntaTapentadol Hcl | 18 | $28,327 |
| Fentanyl | 227 | $24,045 |
| Nucynta ErTapentadol Hcl | 20 | $23,477 |
| Morphine Sulfate ErMorphine Sulfate | 740 | $20,804 |
| LyricaPregabalin | 15 | $15,944 |
| Hydromorphone ErHydromorphone Hcl | 32 | $10,770 |
| Pregabalin | 393 | $9,266 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 66 | $8,289 |
| MovantikNaloxegol Oxalate | 13 | $5,360 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Xtampza Er, Belbuca, Nucynta, Nucynta Er | $660 | $248,081439 claims |
| PfizerLyrica | $80 | $15,94415 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 278 interventional pain medicine providers in Florida.
Other interventional pain medicine in Jacksonville
- Justin MannJacksonville$243K
- Huber Matos-GarsaultJacksonville$48K
- Justin AlfonsoJacksonville$33K
- Kenneth EaddyJacksonville$28K
- David SalekJacksonville$25K
- Maggie GarciaJacksonville$22K
- Alexis JimenezJacksonville$18K
- Ajay AntonyGainesville$1.9M
- Louis RasoJupiter$1.6M
- Gilbert MbeoOrlando$1.4M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.